Israel’s TruLeaf Medical has received approval from the Helsinki Committee to begin human trials of its minimally invasive Mitral Valve Replacement procedure. The Israel Innovation Authority awarded TruLeaf an additional NIS 1.5 million, to make a total of NIS 11.5 million.

https://www.prnewswire.com/il/news-releases/a-new-era-in-heart-surgery–israeli-biomed-company-truleaf-medicals-two-needle-sticks-procedure-for-mitral-valve-replacement-302194644.html